Effect of high dose vitamin D3 on the HIV-1 reservoir: A pilot randomised controlled trial
Introduction: Antiretroviral therapy for people living with HIV-1 must be taken lifelong due to the persistence of latent virus in long-lived and proliferating CD4+ T cells. Vitamin D3 is a steroidal gene transcription regulator which exerts diverse effects on immune and epithelial cells including r...
Saved in:
Main Authors: | Matthew C. Pitman (Author), Niamh Meagher (Author), David J. Price (Author), Ajantha Rhodes (Author), J. Judy Chang (Author), Barbara Scher (Author), Brent Allan (Author), Alan Street (Author), James H. McMahon (Author), Thomas A. Rasmussen (Author), Paul U. Cameron (Author), Jennifer F. Hoy (Author), Stephen J. Kent (Author), Sharon R. Lewin (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
No residual virus replication in a randomised trial of dolutegravir intensification
by: T.A. Rasmussen, et al.
Published: (2017) -
Impact of anti-PD-1 and anti-CTLA-4 on the HIV reservoir in vivo: AMC-095 Study
by: SharonR Lewin, et al.
Published: (2019) -
OP 1.8 - 00204 Romidepsin in combination with the BCL-2 antagonist venetoclax synergistically reduce the size of the HIV reservoir
by: Y. Kim, et al.
Published: (2022) -
33 Experiences and expectations of participants completing HIV cure-focused clinical trials
by: J.H. McMahon, et al.
Published: (2017) -
HIV-1 populations can persist as active reservoirs in the CNS during ART treatment
by: S.B. Joseph, et al.
Published: (2017)